DaVita HealthCare Partners Inc (DVA) is a Healthcare · Medical Care Facilities company listed on NYSE. Price $183.86 (+0.42%), Market cap $12.75B, P/E ratio 19.12, 52-week low–high $103.87 ~ $200.54.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinic
Financial statements, price targets, institutional (13F) holdings and related news for DaVita HealthCare Partners Inc are updated in real time on BlackAll Trade.
DaVita HealthCare Partners Inc trades at $183.86 (+0.42%). Real-time quotes and charts are available on BlackAll Trade.
DaVita HealthCare Partners Inc has a market cap of about $12.75B. Its P/E ratio is 19.12.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in